glyceraldehyde 3-phosphate dehydrogenase (304-313) has been researched along with bradykinin in 1 studies
| Studies (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Trials (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Recent Studies (post-2010) (glyceraldehyde 3-phosphate dehydrogenase (304-313)) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 99 | 1 | 18 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | glyceraldehyde 3-phosphate dehydrogenase (304-313) (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, P; Fox, KA; Ludlam, CA; Newby, DE; Witherow, FN | 1 |
1 other study(ies) available for glyceraldehyde 3-phosphate dehydrogenase (304-313) and bradykinin
| Article | Year |
|---|---|
Marked bradykinin-induced tissue plasminogen activator release in patients with heart failure maintained on long-term angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Bradykinin; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide Fragments; Plethysmography; Substance P; Tissue Plasminogen Activator; Vasomotor System | 2002 |